These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6461110)

  • 1. HLA-restricted cytotoxicity against male-specific (H-Y) antigen after acute rejection of an HLA-identical sibling kidney: clonal distribution of the cytotoxic cells.
    Pfeffer PF; Thorsby E
    Transplantation; 1982 Jan; 33(1):52-6. PubMed ID: 6461110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-restricted cell-mediated cytotoxicity directed against male specific (H-Y) antigen after acute rejection of an HLA-identical sibling kidney.
    Pfeffer PF; Sødal G; Thorsby E
    Scand J Urol Nephrol Suppl; 1981; 64():72-8. PubMed ID: 6216585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T cells recognizing minor transplantation antigens, and possibly a variant of the HLA-B8 molecule. Cause of rejection of an HLA-identical sibling kidney transplant?
    Pfeffer PF; Qvigstad E; Ahonen J; Thorsby E
    Transplantation; 1984 Nov; 38(5):517-22. PubMed ID: 6238461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-specific decreased cell-mediated cytotoxicity in recipients of well functioning, one HLA haplotype-mismatched kidney allografts.
    Pfeffer PF; Thorsby E; Hirschberg H
    Transplantation; 1983 Feb; 35(2):156-60. PubMed ID: 6187111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro.
    Sondel PM; Hank JA; Wendel T; Flynn B; Bozdech MJ
    J Clin Invest; 1983 Jun; 71(6):1779-86. PubMed ID: 6223050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the functional epitopes on different HLA-A2 molecules.
    Goulmy E; van der Poel J; Giphart M; van Rood JJ
    Immunogenetics; 1984; 20(1):13-21. PubMed ID: 6204938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cell-mediated cytotoxicity to the male specific (H-Y) antigen in man.
    Singal DP; Wadia YJ; Naipaul N
    Hum Immunol; 1981 Feb; 2(1):45-53. PubMed ID: 6168617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major histocompatibility complex-restricted H-Y-specific antibodies and cytotoxic T lymphocytes may recognize different self determinants.
    Goulmy E; van Leeuwen A; Blokland E; van Rood JJ; Biddison WE
    J Exp Med; 1982 May; 155(5):1567-72. PubMed ID: 6175722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation.
    Harmon WE; Parkman R; Lavin PT; Grupe WE; Ingelfinger JR; Yunis EJ; Levey RH
    J Immunol; 1982 Oct; 129(4):1573-7. PubMed ID: 6213715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mismatches for two major and one minor histocompatibility antigen correlate with a patient's rejection of a bone marrow graft from a serologically HLA-identical sibling.
    Lienert-Weidenbach K; Valiante NM; Brown C; White C; Johnston-Dow L; McGinnis M; Krausa P; Lakes DM; Wolf JL; Blume KG; Parham P
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):255-60. PubMed ID: 9450920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major histocompatibility complex-restricted antibody reactivity mainly, but not exclusively, directed against cells from male donors.
    van Leeuwen A; Goulmy E; van Rood JJ
    J Exp Med; 1979 Nov; 150(5):1075-83. PubMed ID: 501284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of antiidiotypic antibodies to donor HLA-A2 following blood transfusions in a highly sensitized HLA-A2+ recipient.
    Burlingham WJ; Pan MH; Mason B; Ceman S; Sollinger HW
    Transplantation; 1988 Jun; 45(6):1066-71. PubMed ID: 3289148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
    Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg JH; Vossen J; Gratwohl A; Vogelsang GB; van Houwelingen HC; van Rood JJ
    N Engl J Med; 1996 Feb; 334(5):281-5. PubMed ID: 8532022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens.
    Voogt PJ; Fibbe WE; Marijt WA; Goulmy E; Veenhof WF; Hamilton M; Brand A; Zwann FE; Willemze R; van Rood JJ
    Lancet; 1990 Jan; 335(8682):131-4. PubMed ID: 1967432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human minor histocompatibility antigen which appears to segregate with the major histocompatibility complex.
    Vinci G; Masset M; Semana G; Vernant JP
    Transplantation; 1994 Aug; 58(3):361-7. PubMed ID: 8053061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells.
    Marijt WA; Veenhof WF; Brand A; Goulmy E; Fibbe WE; Willemze R; van Rood JJ; Falkenburg JH
    J Exp Med; 1991 Jan; 173(1):101-9. PubMed ID: 1985117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of HLA restricted anti-minor histocompatibility antigen(s) reactive cells from skin GVHD lesions.
    Reinsmoen NL; Kersey JH; Bach FH
    Hum Immunol; 1984 Dec; 11(4):249-57. PubMed ID: 6392220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
    Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.